CN103235896A - Internet of things with lithium battery as power supply and for monitoring and treating hyperlipemia - Google Patents
Internet of things with lithium battery as power supply and for monitoring and treating hyperlipemia Download PDFInfo
- Publication number
- CN103235896A CN103235896A CN2013101720522A CN201310172052A CN103235896A CN 103235896 A CN103235896 A CN 103235896A CN 2013101720522 A CN2013101720522 A CN 2013101720522A CN 201310172052 A CN201310172052 A CN 201310172052A CN 103235896 A CN103235896 A CN 103235896A
- Authority
- CN
- China
- Prior art keywords
- fat
- reducing
- hyperlipemia
- lipid
- food
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Abstract
The invention relates to an internet of things with a lithium battery as power supply and for monitoring and treating hyperlipemia and belongs to the technical field of applications of the internet of things. A first lithium battery employs a antenna to form into electromagnetic fields around through an RFID (Radio Frequency Identification) reader-writer which is powered by a first electric lead; a special treating electric tag of a first hyperlipemia patient is triggered in the electromagnetic fields; the RFID reader-writer obtains and stores information inside the special treating electric tag of the first hyperlipemia patient; and the information is input into a hyperlipemia management computer through a data line to be analyzed, processed and stored. A computer which is used for operating and managing the hyperlipemia through a doctor comprehensively analyses a hyperlipemia patient condition, functions of first lipid-lowering medicines, second lipid-lowering medicines and third lipid-lowering medicines which are stored in a lipid-lowering medicine storage and functions of first lipid-lowering food, second lipid-lowering food and third lipid-lowering food which are stored in a lipid-lowering food storage according to blood lipid testing data information which is provided through the special treating electric tag of the hyperlipemia patient and selects suitable lipid-lowering medicines and lipid-lowering food according to symptoms to treat the patient timely.
Description
Technical field
The present invention relates to the lithium electricity as the Internet of Things of the monitoring of power supply source and treatment hyperlipemia disease, belong to the Internet of Things applied technical field.
Background technology
The statistics of ministry of Health of China is that national cardiovascular and cerebrovascular disease number reaches 200,000,000 people, cardiovascular and cerebrovascular disease is related with hyperlipemia disease, lipid material content height in the blood or the composition existing problems of lipid can cause cardiovascular and cerebrovascular disease, and investigation shows: the number that exceeds standard of health indicator is up to 50% in people's blood.When blood fat began to exceed standard, human body did not have tangible symptom, and blood fat exceeds standard to certain numerical value, and hyperlipemia patient's symptom constantly occurs: fat, conscious unhappiness, dreaminess, failure of memory, slowness of thinking, headache, alliteration, dizziness, dizzy, tinnitus; Because the blood plasma lipide dysbolism forms artery sclerosis, hypertension, diabetes, fatty liver, and then forms cranial vascular disease, headstroke, cerebral hemorrhage occur until causing human body death.For the people of sitting office, strengthen physical training, increase the consumption of fat, note kind and the quantity of the edible oil of feed every day simultaneously, learn the modern science knowledge of relevant edible oil.May in 2013 Supreme People's Court on the 4th judicial explanation clearly with the highest the sentencing to death of waste oil processing and eating oil; in recent years; minority lawless person is processed into edible oil manufacturing food with the waste oil ' waste oil ' that the restaurant is poured in the trench; make carcinogenic, the poisoning of people; hit the criminal offence of processing waste oil, the protection people health is very necessary.
Because dynamic variation can take place in quantity and the composition of the lipid material in a people's the blood at any time, must carry out real-time monitoring to the dynamic variation of blood fat.Hyperlipemia patient who has made a definite diagnosis only depends on and takes fat-reducing medicament to treat hyperlipemia disease be not enough, must adhere to that fat-reducing medicament and fat-reducing food combine, and just can obtain reasonable result for the treatment of.Fat-reducing medicament has many different compositions, and fat-reducing food also has many kinds, how according to the lipids detection data of the hyperlipemia disease of single human body, select for use suitable fat-reducing medicament and fat-reducing food very important to the ill.Collect the information of hyperlipemia patient, fat-reducing medicament and all many-sides of fat-reducing food, it is very important improving comprehensive application ability.
Summary of the invention
The objective of the invention is to overcome deficiency of the prior art, the Internet of Things of lithium electricity as the monitoring of power supply source and treatment hyperlipemia disease is provided.
The blood fat data message that single human body detects hyperlipemia disease at every turn enters hyperlipemia disease patient's treatment electronic label special, obtained by the rfid interrogator of lithium electricity power supply in hyperlipemia disease patient's the treatment electronic label special behind the long-time repeatedly lipids detection data message of preserving, computing machine by data line input manager hyperlipemia disease is analyzed, handles, is stored, how regulate blood fat in the human body by taking fat-reducing medicament and edible fat-reducing food, revise lipids detection numerical value according to health standards and need manage to realize by Internet of Things.
The hypercholesterolemia that causes the human body blood fat disorder is a kind of hyperlipemia disease, and atherosclerotic is had pathogenic effects, can cause atherosclerosis such as palsy, coronary heart disease, lower limb vascular disease, payes attention to the control cholesterol, could effectively prevent and treat hyperlipemia disease.As long as someone has thought the control hyperlipemia disease fat-reducing, in fact, is engraved in during bad cholesterol in the blood vessel and impairs one's health, and causes serious cordis and cerebral accident.The cardiovascular disease that is mainly caused by hyperlipemia in the cause of the death of Chinese residents accounts for 40%, and many hyperlipemia patients do not take the content that fat-reducing medicament reduces the LDL-C in the blood.After U.S. hyperlipemia patient took medicine and controls cholesterol, beginning in 1980 was declined to a great extent by the death toll that hyperlipemia disease causes coronary heart disease.The curative effect of stanin fat-reducing medicament has surpassed other class fat-reducing medicaments.Fat-reducing medicament commonly used has cholic acid integrated agent, HMG-COA reductase inhibitor, nicotinic acid, acipimox, hexanicit, and T-CHOL and triglyceride reducing fall in main pharmacological action exactly.The bent beneficial fat health tablet in sky that Beijing produces contains Lovastatin, takes effective.Fat-reducing food has oat, apple, garlic, living green onion, corn, sweet potato, bean product, glossy ganoderma, mushroom, auricularia auriculajudae etc., because blood fat quantity and the classification of each hyperlipemia patient in certain period is different, manage by Internet of Things, the information of integrated use each side, rationally select for use and arrange in pairs or groups fat-reducing medicament and fat-reducing food could the high-efficiency prevention and control hyperlipemia diseases.
In order to solve the problems of the technologies described above, the present invention is achieved by the following technical solutions:
Treatment electronic label special 1 by the hyperlipemia disease patient, rfid interrogator 2, conductor wire first 3, lithium ion battery first 4, data line 5, middleware 6, conductor wire second 7, lithium ion battery second 8, the computing machine 9 of management hyperlipemia disease, fat-reducing medicament storehouse 10, fat-reducing food storehouse 11, fat-reducing medicament first 12, fat-reducing medicament second 13, fat-reducing medicament the third 14, fat-reducing food first 15, fat-reducing food second 16, the fat-reducing food the third 17 common lithium electricity of forming are as the Internet of Things of the monitoring of power supply source and treatment hyperlipemia disease;
Conductor wire first 3 is installed in rfid interrogator 2, lithium ion battery first 4 and read-write equipment, in the electromagnetic field of rfid interrogator 2, be mounted with hyperlipemia disease patient's treatment electronic label special 1, between the computing machine 9 of rfid interrogator 2 and management hyperlipemia disease, middleware 6 is installed, lithium ion battery second 8 is installed in middleware 6, conductor wire second 7, in middleware 6 and fat-reducing medicament storehouse 10, the computing machine 9 of installation administration hyperlipemia disease between the fat-reducing food storehouse 11, in fat-reducing medicament storehouse 10, place fat-reducing medicament first 12, fat-reducing medicament second 13, fat-reducing medicament the third 14 is placed fat-reducing food first 15 in fat-reducing food storehouse 11, fat-reducing food second 16, fat-reducing food the third 17;
Rfid interrogator 2 is connected with middleware 6 by data line 5, middleware 6 is connected by the computing machine 9 of data line 5 with the management hyperlipemia disease, the computing machine 9 of management hyperlipemia disease is connected with fat-reducing medicament storehouse 10 by data line 5, and the computing machine 9 of management hyperlipemia disease is connected with fat-reducing food storehouse 11 by data line 5.
Lithium ion battery first 4 and lithium ion battery second 8 are cobalt acid lithium ion battery or LiFePO4 ion battery.
Compared with prior art, the invention has the beneficial effects as follows: 1. hyperlipemia disease patient's treatment electronic label special stores the blood fat data message of the hyperlipemia disease of repeated detection, diagnosis, the single human body for the treatment of, can use the data message that detects blood fat by rfid interrogator and computing machine, effectively prevent and treat hyperlipemia disease.2. the lithium ion battery volume is little, and electric capacity is big, the use of can charging repeatedly, and it is very convenient to power.3. according to hyperlipemia patient's blood fat numerical value and the state of an illness, pass through computer network, from the fat-reducing medicament storehouse, choose suitable fat-reducing medicament to the ill, from the fat-reducing food storehouse, choose suitable fat-reducing food to the ill, fat-reducing medicament and the collocation of fat-reducing food science are used, and can obtain the good curative effect of preventing and treating cardiovascular and cerebrovascular diseases.Carry out the Internet of Things network management, improved quality of medical care, reduced medical treatment cost.
Description of drawings
Fig. 1 is structural representation of the present invention.
Embodiment
The rfid interrogator of being powered by the conductor wire first by the lithium ion battery first utilizes antenna to form electromagnetic field around, information in the treatment electronic label special that hyperlipemia disease patient's treatment electronic label special is triggered in electromagnetic field, rfid interrogator obtains the hyperlipemia disease patient stores, and analyzes, handles and store by the computing machine of data line input manager hyperlipemia disease.The lipids detection data message analysis-by-synthesis hyperlipemia patient's who is provided according to hyperlipemia disease patient's treatment electronic label special by the computing machine of doctor's handle management hyperlipemia disease the state of an illness, fat-reducing medicament first, the fat-reducing medicament second that the fat-reducing medicament stock is put and the effect of fat-reducing medicament third, fat-reducing food first, the fat-reducing food second that the fat-reducing food stock is put, the effect of fat-reducing food third select for use suitable fat-reducing medicament and fat-reducing food in time to treat to the ill.
Embodiment during following the present invention incites somebody to action by reference to the accompanying drawings is further described:
Treatment electronic label special 1 by the hyperlipemia disease patient, rfid interrogator 2, conductor wire first 3, lithium ion battery first 4, data line 5, middleware 6, conductor wire second 7, lithium ion battery second 8, the computing machine 9 of management hyperlipemia disease, fat-reducing medicament storehouse 10, fat-reducing food storehouse 11, fat-reducing medicament first 12, fat-reducing medicament second 13, fat-reducing medicament the third 14, fat-reducing food first 15, fat-reducing food second 16, the fat-reducing food the third 17 common lithium electricity of forming are as the Internet of Things of the monitoring of power supply source and treatment hyperlipemia disease;
Conductor wire first 3 is installed in rfid interrogator 2, lithium ion battery first 4 and read-write equipment, in the electromagnetic field of rfid interrogator 2, be mounted with hyperlipemia disease patient's treatment electronic label special 1, between the computing machine 9 of rfid interrogator 2 and management hyperlipemia disease, middleware 6 is installed, lithium ion battery second 8 is installed in middleware 6, conductor wire second 7, in middleware 6 and fat-reducing medicament storehouse 10, the computing machine 9 of installation administration hyperlipemia disease between the fat-reducing food storehouse 11, in fat-reducing medicament storehouse 10, place fat-reducing medicament first 12, fat-reducing medicament second 13, fat-reducing medicament the third 14 is placed fat-reducing food first 15 in fat-reducing food storehouse 11, fat-reducing food second 16, fat-reducing food the third 17;
Rfid interrogator 2 is connected with middleware 6 by data line 5, middleware 6 is connected by the computing machine 9 of data line 5 with the management hyperlipemia disease, the computing machine 9 of management hyperlipemia disease is connected with fat-reducing medicament storehouse 10 by data line 5, and the computing machine 9 of management hyperlipemia disease is connected with fat-reducing food storehouse 11 by data line 5.
Lithium ion battery first 4 and lithium ion battery second 8 are cobalt acid lithium ion battery or LiFePO4 ion battery.
Store the information of blood fat numerical value in the repeated detection blood in the hyperlipemia disease patient's that the hyperlipemia patient of single human body holds the treatment electronic label special, powered to the read-write equipment in the rfid interrogator by the conductor wire first by the lithium ion battery first, rfid interrogator utilizes antenna to form electromagnetic field around, hyperlipemia disease patient's treatment electronic label special receives energy and then the lipids detection numerical information is sent to rfid interrogator from electromagnetic field, rfid interrogator is powered by lithium ion battery second the input of lipids detection numerical information by data line by conductor wire second middleware, middleware screening and filtering information data, effective lipids detection numerical information is flowed to the computing machine of management hyperlipemia disease by data line, computing machine by attending doctor's operational administrative hyperlipemia disease, make a definite diagnosis type and the occurring degree of hyperlipemia disease according to hyperlipemia patient's the state of an illness such as lipids detection numerical information, and send instruction by data line, the fat-reducing medicament first of from the fat-reducing medicament storehouse, depositing, fat-reducing medicament second, pick out stanin fat-reducing medicament in the fat-reducing medicament third, the fat-reducing food first of from the fat-reducing food storehouse, depositing, fat-reducing food second, pick out oat in the fat-reducing food third, the mushroom fat-reducing food carries out reasonably combined use, thereby has obtained the effect of intelligent control hyperlipemia disease.
It is as follows now to enumerate embodiment:
Embodiment one:
The rfid interrogator of being powered by the conductor wire first by cobalt acid lithium ion battery first utilizes antenna to form electromagnetic field around, hyperlipemia disease patient's treatment electronic label special is triggered in electromagnetic field, the interior information for the treatment of electronic label special that rfid interrogator obtains the hyperlipemia disease patient stores, and analyzes, handles and store by the computing machine of data line input manager hyperlipemia disease.Fat-reducing food first, the fat-reducing food second of depositing in the effect of the lipids detection data message analysis-by-synthesis hyperlipemia patient's who is provided according to hyperlipemia disease patient's treatment electronic label special by the computing machine of doctor's handle management hyperlipemia disease the state of an illness, fat-reducing medicament first, the fat-reducing medicament second that the fat-reducing medicament stock is put and fat-reducing medicament third, the fat-reducing food storehouse, the effect of fat-reducing food third select for use suitable fat-reducing medicament and fat-reducing food in time to treat to the ill.
Embodiment two:
The rfid interrogator of being powered by the conductor wire first by LiFePO4 ion battery first utilizes antenna to form electromagnetic field around, hyperlipemia disease patient's treatment electronic label special is triggered in electromagnetic field, the interior information for the treatment of electronic label special that rfid interrogator obtains the hyperlipemia disease patient stores, and analyzes, handles and store by the computing machine of data line input manager hyperlipemia disease.Fat-reducing food first, the fat-reducing food second of depositing in the effect of the lipids detection data message analysis-by-synthesis hyperlipemia patient's who is provided according to hyperlipemia disease patient's treatment electronic label special by the computing machine of doctor's handle management hyperlipemia disease the state of an illness, fat-reducing medicament first, the fat-reducing medicament second that the fat-reducing medicament stock is put and fat-reducing medicament third, the fat-reducing food storehouse, the effect of fat-reducing food third select for use suitable fat-reducing medicament and fat-reducing food in time to treat to the ill.
Claims (2)
1. the lithium electricity is as the monitoring of power supply source and the Internet of Things for the treatment of hyperlipemia disease, it is characterized in that, by hyperlipemia disease patient's treatment electronic label special (1), rfid interrogator (2), conductor wire first (3), lithium ion battery first (4), data line (5), middleware (6), conductor wire second (7), lithium ion battery second (8), the computing machine (9) of management hyperlipemia disease, fat-reducing medicament storehouse (10), fat-reducing food storehouse (11), fat-reducing medicament first (12), fat-reducing medicament second (13), fat-reducing medicament third (14), fat-reducing food first (15), fat-reducing food second (16), fat-reducing food third (17) is formed the lithium electricity jointly as the Internet of Things of the monitoring of power supply source and treatment hyperlipemia disease;
Conductor wire first (3) is installed in rfid interrogator (2), lithium ion battery first (4) and read-write equipment, in the electromagnetic field of rfid interrogator (2), be mounted with hyperlipemia disease patient's treatment electronic label special (1), between the computing machine (9) of rfid interrogator (2) and management hyperlipemia disease, middleware (6) is installed, lithium ion battery second (8) is installed in middleware (6), conductor wire second (7), in middleware (6) and fat-reducing medicament storehouse (10), the computing machine (9) of installation administration hyperlipemia disease between the fat-reducing food storehouse (11), in fat-reducing medicament storehouse (10), place fat-reducing medicament first (12), fat-reducing medicament second (13), fat-reducing medicament third (14) is placed fat-reducing food first (15) in fat-reducing food storehouse (11), fat-reducing food second (16), fat-reducing food third (17);
Rfid interrogator (2) is connected with middleware (6) by data line (5), middleware (6) is connected by the computing machine (9) of data line (5) with the management hyperlipemia disease, the computing machine (9) of management hyperlipemia disease is connected with fat-reducing medicament storehouse (10) by data line (5), and the computing machine (9) of management hyperlipemia disease is connected with fat-reducing food storehouse (11) by data line (5).
2. lithium electricity according to claim 1 is characterized in that as the monitoring of power supply source and the Internet of Things for the treatment of hyperlipemia disease, and described lithium ion battery first (4) and lithium ion battery second (8) are cobalt acid lithium ion battery or LiFePO4 ion battery.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2013101720522A CN103235896A (en) | 2013-05-12 | 2013-05-12 | Internet of things with lithium battery as power supply and for monitoring and treating hyperlipemia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2013101720522A CN103235896A (en) | 2013-05-12 | 2013-05-12 | Internet of things with lithium battery as power supply and for monitoring and treating hyperlipemia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103235896A true CN103235896A (en) | 2013-08-07 |
Family
ID=48883936
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2013101720522A Pending CN103235896A (en) | 2013-05-12 | 2013-05-12 | Internet of things with lithium battery as power supply and for monitoring and treating hyperlipemia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103235896A (en) |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050148828A1 (en) * | 2003-12-30 | 2005-07-07 | Kimberly-Clark Worldwide, Inc. | RFID system and method for tracking environmental data |
| CN101116077A (en) * | 2005-02-11 | 2008-01-30 | 卡迪纳尔健康303公司 | Identification system and method for medication management |
| CN101143234A (en) * | 2006-09-14 | 2008-03-19 | 上海中策工贸有限公司 | Transfusion device monitoring system |
| US20080094215A1 (en) * | 2006-10-18 | 2008-04-24 | Amador Erick S | Method and Apparatus for Using a RFID Paging Infrastructure |
| CN202306556U (en) * | 2011-09-23 | 2012-07-04 | 厦门市美利捷科技有限公司 | Management system for medicament dispatching |
| CN102695045A (en) * | 2012-06-14 | 2012-09-26 | 北京航天通联物网科技有限公司 | Video intelligent tracing system for RFID (Radio Frequency Identification Device) |
-
2013
- 2013-05-12 CN CN2013101720522A patent/CN103235896A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050148828A1 (en) * | 2003-12-30 | 2005-07-07 | Kimberly-Clark Worldwide, Inc. | RFID system and method for tracking environmental data |
| CN101116077A (en) * | 2005-02-11 | 2008-01-30 | 卡迪纳尔健康303公司 | Identification system and method for medication management |
| CN101143234A (en) * | 2006-09-14 | 2008-03-19 | 上海中策工贸有限公司 | Transfusion device monitoring system |
| US20080094215A1 (en) * | 2006-10-18 | 2008-04-24 | Amador Erick S | Method and Apparatus for Using a RFID Paging Infrastructure |
| CN202306556U (en) * | 2011-09-23 | 2012-07-04 | 厦门市美利捷科技有限公司 | Management system for medicament dispatching |
| CN102695045A (en) * | 2012-06-14 | 2012-09-26 | 北京航天通联物网科技有限公司 | Video intelligent tracing system for RFID (Radio Frequency Identification Device) |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Penniston et al. | Quantitative assessment of citric acid in lemon juice, lime juice, and commercially-available fruit juice products | |
| Sura et al. | Dysphagia in the elderly: management and nutritional considerations | |
| Kickbusch | Health literacy: an essential skill for the twenty‐first century | |
| CN103353980A (en) | Health service system based on intelligentized set-top box | |
| Hudson et al. | Remote physiological monitoring: clinical, financial, and behavioral outcomes in a heart failure population | |
| Kowanko | The role of the nurse in food service: A literature review and recommendations | |
| CN107536603A (en) | A kind of full-time intelligent health monitoring equipment and its management method | |
| So et al. | Ictal asystole and SUDEP | |
| CN103235896A (en) | Internet of things with lithium battery as power supply and for monitoring and treating hyperlipemia | |
| CN206411675U (en) | A kind of intelligent Western medicine access system | |
| CN205621072U (en) | Community's intelligence endowment platform | |
| Gloria et al. | Promoting food bank as a way of ensuring food security in Nigeria. | |
| CN105852830A (en) | Mental health monitoring system and method based on cloud platform | |
| CN201921440U (en) | Interactive exercise device with safety monitoring function | |
| CN105512476B (en) | A kind of method and intelligent wearable device of data acquisition | |
| Zhu | Community based health promotion program for stroke in Malaysia | |
| CN106951688A (en) | A kind of dialectical system of traditional Chinese medical science four methods of diagnosis parting | |
| Joo et al. | Survey on the korean medicine doctor's awareness of the extension and activation of herbal medicine preparations insurance benefits | |
| CN203858701U (en) | Self-service medicine selling system based on regional medical treatment | |
| US9415003B2 (en) | Skin care method and kit | |
| Malaysia | Food security: concepts and definitions | |
| Ostrowska | In and Out of Communism: The macrosocial context of health in Poland | |
| CN108335730A (en) | A kind of wired home data center | |
| CN106377036A (en) | Family doctor-based intelligent medicine chest | |
| CN206670760U (en) | A kind of gravity monitoring system for ginkgo soft and soggyization charging engineering |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20130807 |